Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)

Sponsor
Fudan University
Study ID
NCT06102161
Phase
PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Wedge resection — PROCEDURE
    Wedge resection is a surgical procedure that is done to remove a wedge-shaped section of lung tissue, usually for treating lung cancer. A wedge resection is less invasive than some of the other surgical options used to remove lung cancer.

Study Details

This is a clinical trial from the Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1020. The goal of this clinical trial is to confirm the therapeutic effect of Wedge resection for ground-glass opacity-featured lung cancer with a size less than 2cm and a consolidation-to-tumor ratio between 0.25 to 0.5.

Key Dates

Start date
Nov 30, 2023
Status verified
Oct 2023
Primary completion
Nov 30, 2025
Completion
Nov 30, 2030

Study Design

Enrollment
286 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Wedge resection
    Wedge resection is performed for early-stage lung cancer to remove a wedge-shaped section of lung tissue.

Primary Outcome Measure

5-year overall survival [ Time Frame: 5 years ]

Central Contacts

Related Studies